Voce Capital Management’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$4.97M Sell
507,941
-68,897
-12% -$700K 8.59% 6
2023
Q1
$5.57M Hold
576,838
8.34% 4
2022
Q4
$4.36M Hold
576,838
2.51% 6
2022
Q3
$3.46M Sell
576,838
-32,548
-5% -$209K 2.25% 6
2022
Q2
$3.28M Hold
609,386
1.64% 7
2022
Q1
$3.04M Hold
609,386
1.2% 8
2021
Q4
$3.18M Hold
609,386
1.13% 7
2021
Q3
$3.38M Buy
609,386
+159,643
+35% +$1.04M 1.22% 8
2021
Q2
$3.22M Buy
449,743
+270,044
+150% +$2.34M 1.15% 8
2021
Q1
$1.82M Buy
+179,699
New +$1.69M 0.82% 8

Other funds holding VMD

Voce Capital Management's VMD Position: Q2 2023 in Review

Voce Capital Management reduced its Viemed Healthcare (VMD) stake by 12% in Q2 2023, selling an estimated $700K and leaving 507,941 shares worth $4.97M. The position accounts for 8.59% of the portfolio, ranked #6.

Voce Capital Management first reported a position in VMD in Q1 2021 and has held it in 10 quarters since. The position peaked at $5.57M in Q1 2023. 103 funds tracked by Wall St. Rank hold VMD as of Q2 2023.

  • Voce Capital Management held 507,941 shares of Viemed Healthcare worth $4.97M as of Q2 2023.
  • Voce Capital Management sold 68,897 Viemed Healthcare shares in Q2 2023, an estimated $700K.
  • Viemed Healthcare made up 8.59% of Voce Capital Management's portfolio in Q2 2023, its #6 holding.
  • Voce Capital Management first reported a position in Viemed Healthcare in Q1 2021 and has held it in 10 quarters since.
  • Voce Capital Management's Viemed Healthcare position peaked at $5.57M in Q1 2023.
  • 103 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2023.

Based on Voce Capital Management's 13F filing for Q2 2023, filed 31 Jul 2023.